Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections |
Recalls
- Oct 29, 2024 · Class III · Dr. Reddy's Laboratories, Inc.
Failed Tablet/Capsule Specifications
Lots: Lot #: C5406201, Exp 03/31/2028 - Aug 6, 2024 · Class II · Dr. Reddy's Laboratories, Inc.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Lots: a) NDC 55111-684-01 Lots C2207525, Exp 5/31/2026; C2212902, Exp 11/30/2026. b) NDC 55111-684-05 Lots C2207526, Exp 5/31/2026; C2210751, C2210752, Exp 9/30/2026; C2212765, C2212766, Exp 11/30/2026; C2301027, C2301063, C2301187, C2301188, C2301247, Exp 12/31/2026; C2301356, C2301388, C2301494, C23… - Aug 6, 2024 · Class II · Dr. Reddy's Laboratories, Inc.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Lots: a)NDC 55111-683-01 Lots C2207527, Exp 5/31/2026; C2210864, Exp 9/30/2026; C2213018, Exp 11/30/2026. b)NDC 5511-683-05 Lots C2207528, Exp 5/31/2026; C2210860, Exp 9/30/2026; C2213016, C2213017, Exp 11/30/2026; C2301852, C2302056, C2302057, Exp 1/31/2027. - Aug 6, 2024 · Class II · Dr. Reddy's Laboratories, Inc.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Lots: a)NDC 55111-682-01 Lots C2207529, Exp 5/31/2026; C2210993, Exp 9/30/2026. b)NDC 55111-682-05 Lots C2207530, Exp 5/31/2026; C2210992, C2210994, Exp 9/30/2026; C2213304, C2213305, Exp 11/30/2026. - Aug 29, 2013 · Class II · Dr. Reddy's Laboratories, Inc.
Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.
Lots: Lot # L300192; Exp. 05/2017
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ibuprofen: every company that makes it
- Form
- tablet, oral
- Strength
- 400 mg
- Approval
- ANDA ANDA075682
- On the market since
- Nov 20, 2008
- Package NDCs
55111-682-0155111-682-0555111-682-09- Official label
- DailyMed (National Library of Medicine), updated Jul 2, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?